Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Abstract Background This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. Methods We conducted an observational prospective study, on 232 patients with chronic kidn...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-01-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-020-1687-1 |